Neurolief

I am very excited about these results and the impact that this therapy will have on patients suffering from depression and not responding to first line treatments - all from the comfort of their homes and their schedules!

We are thrilled to announce the successful completion of our pivotal clinical trial for the treatment of Major Depressive Disorder! This study marks a historic milestone as the first-ever Randomized Controlled Trial (RCT) to demonstrate success in a non-pharmacological home therapy for Treatment Resistant Major Depression. The success of this pivotal trial not only demonstrates the efficacy and safety of our groundbreaking brain neuromodulation technology but also highlights its transformative potential in revolutionizing depression and mental health treatment. And as Dr. Mark George, distinguished professor of psychiatry, radiology, and neuroscience and director of the Medical University of South Carolina (MUSC) Brain Stimulation Division, said: “This is a great day for patients with depression”. https://lnkd.in/dzi67unx #MentalHealth #DepressionTreatment #Innovation #ClinicalTrial #MentalHealthRevolution#BrainNeuromodulation#

Migraine is often misunderstood, leading to misdiagnoses and inadequate treatment options. It’s time to change that. Our latest blog post is a must-read for anyone committed to advancing migraine care and innovation. Share this with your network to spread awareness and foster a more informed community. Together, we can make a significant impact on the lives of those suffering from migraines. . . . . . . . #Healthcare #Migraine #Neurology #MedicalInnovation #InvestmentOpportunities #Relivion #MedicalResearch #HealthTech #DoctorCommunity

As healthcare professionals, understanding the patient experience is crucial in evaluating new treatments. Here’s a firsthand account of what using Relivion feels like, a question frequently asked by prospective patients, from Kaylon Evans, a real Relivion user. 🔍 Why Relivion? *Non-invasive *Clinically proven *User-friendly technology We believe Relivion offers a promising avenue for #migraine relief and represents a significant #investment opportunity in #healthcare #technology.

In our latest blog post, we dive into five approaches that can help patients approach #migraine pain management, including the use of #neuromodulation technologies like Relivion MG. . . . . . . #neuroscience #migrainepain #innovation #blog https://lnkd.in/gmQpx9KX

Meet Kaylon Evans, a #migraine warrior who found relief with Relivion MG. His testimonial is a beacon of hope for those battling migraine disease. Now, with Relivion more accessible and affordable than ever, relief is within reach. Relivion® MG is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older. It is a prescription device to be self-used at home. As with any treatment, results may vary.

Physicians eager to incorporate our breakthrough migraine therapy into their practice can now sign up for streamlined training and seamless onboarding. Ready to take the first step toward empowering your patients with innovative care? Visit https://lnkd.in/gK9EBmfD #Relivion #MigraineTherapy #MedicalInnovation

When trying to understand the complexities of migraine disease, it's crucial to explore the intricate relationship between the trigeminocervical complex (TCC), the trigeminal and occipital nerves, and how they contribute to migraine pain. This new blog post aims to demystify this connection, providing insights into the mechanisms behind #migraine and potential avenues for relief. Read more: https://lnkd.in/gtac7Cdr

Migraine does not equal head pain. Migraine causes dysfunction of the nervous system and impacts the entire body, not just the head. Share this post to help raise awareness and support for this debilitating disease. —— If you or your patients are struggling to find a treatment that improves your quality of life with migraine, Relivion MG is here to help. Relivion MG is a non-invasive, drug-free, clinically proven, FDA-cleared neuromodulation device for the treatment of migraine. Relivion’s breakthrough technology applies neurostimulation to 6 nerve branches associated with migraine pain, both the occipital AND trigeminal nerves. Follow us on Instagram at @RelivionMG —— #Migraine #Symptoms #MigraineSymptoms #HeadPain #Nausea #VestibularDysfunction #Mood #MuscleWeakness #Fatigue #BodyPain #ChronicPain #VisionLoss #NeckPain #MigraineAttack #Migrain #ChronicMigraine #Neuromodulation #MigraineSupport #MigraineCommunity #MigraineTreatment #CognitiveDysfunction

We are proud to announce the approval of Relivion by the Japanese Ministry of Health, Labor and Welfare (MHLW). This approval marks a historic moment for Neurolief and its partner Sawai Pharmaceutical Co., Ltd, as Relivion becomes the first neuromodulation device approved in Japan for at-home use in the acute treatment of migraine. https://lnkd.in/gtnhpFBJ